Hepatoprotective and antioxidant effects of lycopene on non-alcoholic fatty liver disease in rat

Figure 1 Effects of lycopene on body weight (A) and liver coefficient (B). ^bP < 0.01 vs control group; ^cP < 0.05, ^dP < 0.01 vs model group. Ly: Lycopene.

Figure 2 Appearance of rat liver tissue (A) and histopathological examination by HE (B, 200 ×). I: Control group; II: Model group; III: Ly 5 mg/kg group; IV: Ly 10 mg/kg group; V: Ly 20 mg/kg group. Ly: Lycopene.

Figure 3 Representative photographs of immunological histological chemistry examination (200 ×). A: TNF-α; B: CYP2E1. I: Control group; II: Model group; III: Ly 5 mg/kg group; IV: Ly 10 mg/kg group; V: Ly 20 mg/kg group; VI: Quantification of TNF-α (A-VI) and CYP2E1 (B-VI) stained cells. The results are expressed as mean ± SD of 12 rats. ^bP < 0.01 vs control group; ^cP < 0.05, ^dP < 0.01 vs model group. Ly: Lycopene.